\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Adherence Status and Associated Factors of Iron and Folic Acid Supplementation among Pregnant Women Attending Ante Natal Care at},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2019 2019-01-15 (revised: 39 Year 2019 15 January 2019)}
\def\TheID{\makeatother }
\def\TheDate{2019 2019-01-15}
\title{Adherence Status and Associated Factors of Iron and Folic Acid Supplementation among Pregnant Women Attending Ante Natal Care at}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Marta  Tessema}

             \affil[1]{  Jimma University}

\renewcommand\Authands{ and }

\date{\small \em Received: 11 December 2018 Accepted: 31 December 2018 Published: 15 January 2019}

\maketitle


\begin{abstract}
        


Background: Iron and folic acid supplementation is the feasible and cost-effective strategy to control and prevent anemia in pregnancy. In Ethiopia, the national data suggests that from all pregnant women supplemented with these tablets, only 0.4% consumed more than 90 tablets during their pregnancy time. The factors for this low adherence are not clearly known.Objective: To assess adherence status and associated factors of iron and folic acid supplementation among pregnant women attending Antenatal care in Jimma town public health facilities, 2017.Method: An institution based cross-sectional study design was employed using both quantitative and qualitative methods on 226 pregnant women attending Antenatal care clinic in Jimma Town public health facilities from April 10 -May 10/2017. Systematic random sampling method was used. A Pre-tested structured questionnaire was used for interview mand analyzed using chi-square test.

\end{abstract}


\keywords{adherence, pregnant women, iron, folic-acid, antenatal care.}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{Background}]{Background}\par
ron deficiency anemia during pregnancy is a serious public health problem due to its high prevalence and potential negative consequences. Estimates from the World Health Organization report that from 35\% to 75\% (56\% on average) of pregnant women in developing countries, and 18\% of women from industrialized countries are anemic  {\ref (WHO, 1992)}. Studies done by  {\ref (Haidar and Pobocik)} also indicate that one in every three women had anemia and deficiency of folic acid, while one in every five had iron deficiency anemia, indicating that both folic acid and iron deficiencies constitute the major micronutrient deficiencies in Ethiopian women \hyperref[b15]{(Haidar and Pobocik, 2009)}. It can lead to several adverse birth outcomes including low birth weight, preterm delivery, stillbirth, and maternal and neonatal mortality  {\ref (WHO, 1992)}. Infants are among the vulnerable groups of iron deficiency, since there is a link between maternal and neonatal iron status, interventions on infant alone will be insufficient to decrease infant iron status  {\ref (Harris.ED.1992;} {\ref WHO, 1992)}.\par
Oral iron and folic acid supplementation are a feasible and cost-effective strategy that exists for iron deficiency anemia prevention and control  {\ref (CDC, 1998;} {\ref WHO, 1989)}. Studies done on well-nourished Danish women, shows that: women were given either a placebo or 66 mg Fe/d as ferrous fumarate beginning week 16 of pregnancy. At term, in the placebo group, 92\% of women had no bone marrow iron, 65\% of women had latent iron deficiency, and 18\% of women had iron deficiency anemia. Even in the group supplemented with iron, iron stores at term were exhausted in 54\% of women, although only 6\% of women had latent iron deficiency and no women had iron deficiency anemia (US, National Academy Press, 1993). Infants born to anemic mothers were 5.7 more likely to become anemic than women born to nonanemic mothers  {\ref (Colomer J, et al. 1990}).\par
the feasible and cost-effective strategy to control and prevent anemia in pregnancy. In Ethiopia, the national data suggests that from all pregnant women supplemented with these tablets, only 0.4\% consumed more than 90 tablets during their pregnancy time. The factors for this low adherence are not clearly known.\par
Objective: To assess adherence status and associated factors of iron and folic acid supplementation among pregnant women attending Antenatal care in Jimma town public health facilities, 2017.\par
Method: An institution based cross-sectional study design was employed using both quantitative and qualitative methods on 226 pregnant women attending Antenatal care clinic in Jimma Town public health facilities from April 10 -May 10/2017. Systematic random sampling method was used. A Pre-tested structured questionnaire was used for interview and analyzed using chi-square test. A P-value <0.05 was declared as statistically significant. For qualitative data, 8 IDI was done from purposively selected6 pregnant women and 2 Midwifes. The data was analyzed using thematic analysis method and triangulated with quantitative data.\par
Result: 226 pregnant women was participated in the study with 100\% response rate. 8 IDI respondents were included in the data analysis for triangulation. The adherence rate was 136(60\%)and factors significantly associated with adherence to Iron and folic acid supplementation were, time of registration for Antenatal care, X 2 (1, N=226) = 7.3997, p= 0.006523, knowledge of anemia, X 2 (1, N=226) = 24.4671, p= 0.00001, history of anemia during current pregnancy X 2 (1, N=226) = 5.5078, p= 0.018932, and gravidity, X 2 (1, N=226) = 22.9821, p=0.00001. Forgetfulness and fear of side effects were the major reasons for missing the doses of tablets. 
\section[{Conclusion:}]{Conclusion:}\par
Iron and folic acid adherence rate were low in the study area. Thus, increasing knowledge of pregnant women about iron and folic acid supplementation, through adequate counseling, community education helps to increase adherence.\par
Several developing countries are now implementing iron/folic acid supplementation programs, but only a few countries had significant improvement in anemia control and prevention. Studies conducted in different parts of the world (Asia, Latin America and African countries) have shown low adherence of women taking daily iron/folic acid supplementations and this is among one of the main reasons why IFAS programs have been less effective \hyperref[b21]{(Mithra et al., 2014;} {\ref Bekele et al. 2015;}\hyperref[b33]{Wendt et al., 2015)}. In Ethiopia, iron/foliate supplementation is the main strategy for Anemia control and prevention. However, adherence rate remains very low. The national data suggests that from all pregnant women supplemented with IFA tablets only 0.4\% consumed more than 90 tablets during their pregnancy time \hyperref[b12]{(Fiedler et al. 2014)}. Eighty-three percent of women did not take iron tablets during their last pregnancy. Fifteen percent took for less than 60 days, and less than 1 percent took for three months or more during their last pregnancy  {\ref (CSA, 2011)}  
\section[{Objectives a) General Objective}]{Objectives a) General Objective}\par
To assess adherence status and associated factors of Iron and folic acid supplementations among pregnant women attending Ante natal care clinic at Jimma town public health facilities, south west of Ethiopia, 2017. 
\section[{b) Specific Objectives}]{b) Specific Objectives}\par
To determine adherence level of Iron and folic acid supplementations among pregnant women attending, Ante natal care clinic at Jimma town public health facilities, south west of Ethiopia, 2017.\par
To identify factors associated with adherence to Iron and folic acid supplementation among pregnant women attending Ante natal care clinic at Jimma town public health facilities, south west of Ethiopia, 2017. 
\section[{III.}]{III.} 
\section[{Methods}]{Methods} 
\section[{a) Study design, period and area}]{a) Study design, period and area}\par
Institutional based cross-sectional study design was employed from April 10 -May 10, 2017 at public health facilities of Jimma town, south west Ethiopia. 
\section[{b) Source population}]{b) Source population}\par
All pregnant women who took IFAS and visited the ANC clinic at Jimma town public health facilities during the study period 
\section[{c) Study Population}]{c) Study Population}\par
All selected pregnant women who took IFAS at least for a month and visited the ANC clinic during the study period. 
\section[{d) Dependent Variables}]{d) Dependent Variables}\par
Iron and folic acid supplementations adherence whereas, Independent variables are, Age, religion, residence, marital status, mother education level, partner education level, support from family, family size, income, number of visits, time of registration, gravidity, parity, trimester, history of previous anemia, history of current anemia, Adequate explanation about the tablets by providers, distance from the health facility, Knowledge on Anemia and knowledge on IFAS. 
\section[{e) Sample size determination}]{e) Sample size determination}\par
The sample size was determined by a single population proportion formula by considering the following assumptions:?? = (??\textunderscore ??/??) ?? * ?? (?? ? ??) ?? ??\par
Where: 
\section[{f) Sample size}]{f) Sample size}\par
From the previous study the proportion of adherence level of IFAS among ANC followers was 37.2\%. By taking 95\% CI, a margin of error 5\%, the sample size comes= 359. Since the source population is <10,000, by taking population correction formula and Considering 10\% non-response rate, the total study subjects were 226-pregnant women. For qualitative data collection, eight IDI was done from six mothers and two midwives who have long time working experience on ANC clinic. 
\section[{g) Sampling techniques}]{g) Sampling techniques}\par
Initially, out of four health centers and two hospitals in the town one hospital and two health centers were selected by using simple random sampling techniques. Then the final sample size was allocated proportionally for each health facilities based on their number of ANC followers. By using the list of ANC registration book as sampling frame, simple random sampling technique were applied. For qualitative study participant were selected purposively from mothers ANC followers and midwifes work on ANC clinic. 
\section[{h) Data collection tool and procedure}]{h) Data collection tool and procedure}\par
Data collection tool was prepared by reviewing different literature and first prepared in English then translated to Oromic language. Interviews were done to collect data from participants. Data was collected by four data collectors and one supervisor who had BSC and MSC respectively. 
\section[{i) Data Quality Assurances}]{i) Data Quality Assurances}\par
The data collectors and supervisors were trained for two days before pre-test on the objective, how to use the questionnaires to ensure consistency. Pre-test was conducted on 5\% of sample size in jimma zone health facility out of town. j) Data analysis Data was analyzed using Pearson chi-square test. Variables found significant when its (p-value ? 0.05). Descriptive statistic including frequency, percentage was used to describe the data. Finally, the results were presented in the form of texts and tables. For qualitative study thematic analysis was done and triangulated with quantitative data.\par
IV. 
\section[{Result a) Socio-demographic Characteristics of study participant}]{Result a) Socio-demographic Characteristics of study participant}\par
A total of 226 pregnant women were participated in the study, making a response rate of 100\%. Majority of 124 (54.0\%) were ?25 years. One hundred ninety (84.1\%) of study participants resided in urban. The vast majority, 112(49.5\%) were Muslim followers, and 214 (94.7\%) of the participants were married. According to mother's response about 26 (11.5\%) and 27 (11.9\%) respondents and respondents' husband were cannot read and write respectively. About 97 (42.9\%) of the study participants were house wife followed by daily laborer 12(5.3\%), and 187(80.97\%) of the study participants had family size of at most three. About 51(22.5\%) of the participants had monthly income of 1000-3000 birr. Table \hyperref[tab_1]{(1}  
\section[{b) Obstetric and Health Facility related characteristics of the respondents}]{b) Obstetric and Health Facility related characteristics of the respondents}\par
One hundred thirty-one (58.0\%) of the respondents were in their second trimester. About 30(13.3\%) of the participants were primigravida, and only 196 (86.7\%) were Multiparous. More than two-third 201(88.9\%) of the respondents visited the ANC clinic within their 16weeks of gestation. More than ninety percent (226) of the respondents, had at most four ANC visits. About 125 (55.3\%) of the respondents spent more than 30 minutes (by foot) to reach the health facility, and 180 (79.6\%) of the respondents got medical advice about IFAS) (Table \hyperref[tab_2]{2}).  
\section[{c) Self-reported rate of Adherence to IFAS and Reasons}]{c) Self-reported rate of Adherence to IFAS and Reasons}\par
One hundred thirty-six (60\%) of pregnant women adhered to IFAS (took ?4 tablets per week in the previous one month preceding the survey) (Figure 1). The leading reason for adherence was getting medical advice (79.6\%) followed by fear of illness if not taking the supplement (20.4\%). Findings from the qualitative part of the study also revealed that most pregnant mothers' main reason for consuming the tablets was getting medical advice from health care providers.  
\section[{60\% 40\%}]{60\% 40\%}\par
Twenty-eight years old, pregnant women said that, "I took IFAS's because the health care providers (both at a health facility and home visit) told me it prevents you from anemia and your fetus from diseases."\par
The other qualitative finding showed that, fear of illness, if tablets are missed was the second main reason to adhere IFAS.\par
Thirty-two years old, pregnant women said that ? "I am forced to take the IFAS, because I fear the illness that would happen to me and my fetus, if I missed the doses of IFAS."\par
Another reason for taking IFAS raised by in-depth interview participants was getting family support. 
\section[{Thirty years old, pregnant women said that ?" I never missed the tablet, because my husband reminds me to take it."}]{Thirty years old, pregnant women said that ?" I never missed the tablet, because my husband reminds me to take it."}\par
From women who missed the doses of IFAS, the leading reason was forgetfulness (88, 38.9\%) followed by fear of side effect (72, 31.9\%). Other reasons for missing the doses of IFAS were the belief that taking IFAS leads a too big baby (56, 24.8\%) and taking too many IFAS tablets, would harm the mother and infant (24, 10.6\%).\par
Findings from the qualitative component also revealed that most pregnant mothers' main reason for missing the doses of tablets was forgetfulness.\par
Twenty-six years old, pregnant women said that ?" Since I forgot, I missed more than half of the tablets. Pills are taken at night time; I spent all day with work, when I returned to home, I will be so exhausted then I will forget them. "\par
A thirty-five years Midwife said that?." the main reason for missing the doses of tablets was forgetfulness, not side effect since we gave them counseling about side effects." 
\section[{d) Knowledge of Anemia and IFAS}]{d) Knowledge of Anemia and IFAS}\par
Accordingly, the median was 47.4\%. About 78 (61.9\%) of the respondents had good knowledge of anemia (scored median and above), and 48 (38.0\%) of the respondents had poor knowledge of anemia (scored below the median. The median was 71.4\%. One hundred five (46.5\%) of the respondents had good knowledge of IFAS (scored median and above), and about 61(26.9\%) of the respondents had poor knowledge of IFAS (scored below the median). 
\section[{e) Factors Associated with Adherence to IFAS}]{e) Factors Associated with Adherence to IFAS}\par
To know the association of predictor variables with IFAS, Pearson chi-square test was used. Four variables: -Gravidity, time of ANC registration, history of anemia during the current pregnancy and having knowledge about anemia were showed an association with p-value (P<0.05).\par
A chi-square test was performed to examine the relation between gravidity and adherent to iron and folic supplementations of pregnant women. The relation between these variables was significant, X 2 (1, N=226) = 22.9821, p=0.00001.Multiparity were more likely than primiparity to be able to adherent to iron and folic supplementations.\par
There is a significant association between registration time and iron adherent and folic supplementations. The relation between these variables was significant, X 2 (1, N=226) = 7.3997, p= 0.006523. Mothers who registered early gestational age (<16 weeks) were more likely to adherent iron and folic supplementations than who were registered lately (>16 weeks). 
\section[{Qualitative finding also supports this finding: Thirty years old, female midwife said that ? "If they come to health facility at early gestational age, we get more time for counseling and knowing each other, that helps them to adhere for IFAS."}]{Qualitative finding also supports this finding: Thirty years old, female midwife said that ? "If they come to health facility at early gestational age, we get more time for counseling and knowing each other, that helps them to adhere for IFAS."}\par
There is a significant association between history of anemia during current pregnancy and adherent to iron and folic supplementations. The relation between these variables was significant, X 2 (1, N=226) = 5.5078, p= 0.018932. Women who had history of anemia during current pregnancy were more likely to be adhered to Iron and folic acid supplementations than those who hadn't. 
\section[{This is supported by qualitative finding: Twenty -eight years old, pregnant women said that ? "I am forced to take IFAS because of I have anemia."}]{This is supported by qualitative finding: Twenty -eight years old, pregnant women said that ? "I am forced to take IFAS because of I have anemia."}\par
There is a significant relationship between knowledge of anemia and adherent to iron and folic supplementations. The relation between these variables was significant, X 2 (1, N=226) = 24.4671, p= 0.00001.Mothers who had good knowledge about anemia had more likely to adhere iron and foliate supplementations.\par
This finding supported by qualitative data. 
\section[{Thirty-two years old pregnant women said that ? "I am forced to take the tablets because I know about anemia that may cause serious complication if I bleed during delivery."}]{Thirty-two years old pregnant women said that ? "I am forced to take the tablets because I know about anemia that may cause serious complication if I bleed during delivery."}\par
Table \hyperref[tab_3]{3}. V. 
\section[{Discussion}]{Discussion}\par
The result revealed that 60\% of pregnant women were adhered to Iron and folic acid supplementation (took ?4 IFAS tablets per week in the previous one month preceding the survey) which is consistence with the study done in Indonesia (53.7\%) \hyperref[b37]{(Wulandari et al. 2013}). However; it is higher than the study done in Mecha district, Northwest Ethiopia (20.4\%) (Bekele et al. 2015), Tigray, Ethiopia (37.2\%) (Abel et al., 2015), Misha district, South Ethiopia (39.2\%) (Abient et al., 2015), Kenya (24.5\%) \hyperref[b11]{(Dinga et al., 2013)}.This difference might be due to difference in study setting, time variation related with currently accelerated maternal and child health promotions, and majority of the respondents being urban residents' this helps to get information from media. It is lower than the study done in South India (64.7\%) \hyperref[b21]{(Mithra et al., 2014)}. The variation may be due difference in geographic locations, socio cultural, healthy life style, inaccessibility of health services and lack of awareness.\par
The study revealed that, women who had history of anemia during current pregnancy had more likely to adhere with Iron and folic acid supplementations. The finding is consistent with other studies conducted in Mecha district, Northwest Ethiopia (Bekele et al. 2015), Tigray, Ethiopia (Abel et al., 2015), Kenya \hyperref[b11]{(Dinga et al., 2013)} and Tanzania \hyperref[b25]{(Ogundipe et al., 2012)}. This might be due to health care providers given more attention for anemic women during counseling which increases client's awareness and knowledge of Iron and folic acid supplementations. The other reason might be due to women's fear of anemia complications for both them self's and their infants, they try to take more pills to be cured from the anemia. Mothers who were registered early for ANC services had more likely adhere to IFAS than those who were late registered. The result of this study is supported by other studies done in Tigray, Ethiopia \hyperref[b1]{(Abel et al., 2015)}, Ethiopia \hyperref[b12]{(Fiedler et al., 2014)}, India \hyperref[b33]{(Wendt et al., 2015)} and Indonesia \hyperref[b32]{(Titaley and Dibley, 2015)}. The reason may be pregnant women who had early registration for ANC services probably had better concern for their pregnancy and had more ANC visits which in turn leads to getting better medical advice and ultimately improved their knowledge about anemia and Iron and folic acid supplementations.\par
The other important factors that had a significant association with Iron and folic acid supplementation adherence was, knowledge of Anemia. A mother who has good knowledge of anemia more likely adherent to IFAS than who had poor knowledge. The finding is supported by other studies done in Eight rural districts of Ethiopia (Samson et al., 2014, and India \hyperref[b21]{(Mithra et al., 2014)}.The possible reason is that those pregnant women who had good knowledge of anemia, were aware of the effect of anemia on pregnancy this may cause fear of anemia complications, this helps them to know the importance of IFAS to alleviate anemia and the problem if missed the tablets. Similarly, the result also indicates that, multipara mothers have, more likely to had adherence of IFAS. The reason may be multipara mothers may have more contact with health care providers during previous pregnancy, so this may improve time to time their knowledge and experience about IFAS, anemia and its complications, finally they can easily adhere to IFAS.\par
In addition to the above-mentioned association the study participant raised different reasons for adherence and non-adherence to iron and folic acid supplementations. Among the reasons that make the pregnant women to be adhered to iron and folic acid supplementations, getting medical advice, partner support and fear of illness if missed the tablets, were the major ones. The finding was supported by the study conducted in Kenya \hyperref[b11]{(Dinga et al., 2013)} and qualitative finding in this study. This can be related with knowledge of both anemia and its complications that results women's fear of the quensquence of anemia, finally this causes adherence to IFAS. The other important reason is knowledge of the benefit of iron and folic acid supplementations that resulted from proper counseling through medical advice from health care providers. Partner support also related with, opportunity not to forget the tablets and giving more concern for the health of the baby and the mother.\par
The other reason of pregnant women for adherence was getting family support. The justification behind is that when pregnant women get family support, they will have an opportunity not to forget the tablets and great concern for adherence. The study was supported by the study conducted in Pakistan .\par
Forgetfulness, misconception and fear of side effect was the most mentioned reason mentioned qualitatively for pregnant women for non-adherence to iron and folic acid supplementations. A possible explanation for forgetfulness as a major reason is that the timing that the tablet is taken. Findings from the qualitative study revealed that since most of health professional advise them to taken at night, pregnant women were forced to forget the tablet because they spent the day time with different activities and they tired and sleep early by forgetting the tablets to take. The finding also supported by other studies done in Misha district, South Ethiopia (Abient et al., 2015), Ethiopia \hyperref[b12]{(Fiedler et al., 2014)}, and South India \hyperref[b21]{(Mithra et al., 2014)}. Misconceptions and fear of side effect like taking the tablets will lead to, too big baby and harm the mother and the infant, were the other reasons of pregnant women mentioned fornot continuously using the tablets. This is probably resulted from getting inadequate counseling during medical advice from health care providers results women's poor knowledge of anemia and IFAS.  
\section[{Conclusions}]{Conclusions}\par
This study revealed that adhered to Iron and folic acid supplementation of the respondent was low. Early time of registration, history of anemia during current pregnancy, knowledge of anemia significantly and gravidity are associated with pregnant women adherence to iron and folic acid supplementations. Getting medical advice and partner support followed by fear of illness if missed were the major reasons that enforce pregnant women to take the tablets. On the other hand, the perceived cause of missing tablet is forgetfulness misconception and fear of side effects. 
\section[{List of Abbreviations}]{List of Abbreviations}\par
ANC?. Antenatal Care, CSA?. Central statistical Agency, EDHS?. Ethiopian Demographic and Health Survey, FMOH? Federal Ministry of Health, IFA?. Iron Folic Acid, IFAS?. Iron Folic Acid Supplementation, IHRERC? Institutional Health Research Ethics Review Committee, NGO??.Non-Governmental Organization, WHO?.World Health Organization. 
\section[{Ethics approval and consent to participate}]{Ethics approval and consent to participate}\par
Ethical clearance was obtained from Jimma University ethical revive board. Official permission was obtained to conduct the study from Jimma town public health facilities. The respondents were informed about the objective and the purpose of the study. There was no coercion to participate in the study and participations were free to decline, giving information at any time without any justification and prejudice. Verbal consents were obtained from each mother. Confidentiality of the information was ensured by not asking the name of the client or other identifiers. 
\section[{Consent for publication}]{Consent for publication}\par
Not applicable in this study.   \begin{figure}[htbp]
\noindent\textbf{1} \par 
\begin{longtable}{P{0.14071332436069986\textwidth}P{0.009152086137281292\textwidth}P{0.3740915208613728\textwidth}P{0.0949528936742934\textwidth}P{0.13842530282637955\textwidth}P{0.09266487213997307\textwidth}}
\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep Year 2019\\
Age Religion\tabcellsep Variable\tabcellsep Ethiopia, 2017 Category Protestant <25 yrs >25 yrs Orthodox Muslim\tabcellsep Frequency 102 124 92 112 21\tabcellsep Percent 45.1 54.9 40.7 49.5 9.3\tabcellsep Volume XIX Issue IV Version I\\
\tabcellsep \tabcellsep Others*\tabcellsep 1\tabcellsep 0.4\tabcellsep D D D D )\\
\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep (\\
\multicolumn{2}{l}{Residence Educational status}\tabcellsep Urban Rural Cannot read and write Can read and write Primary education Secondary and above\tabcellsep 190 36 26 60 97 43\tabcellsep 84.1 15.9 11.5 26.5 42.9 19.1\tabcellsep Medical Research\\
\multicolumn{2}{l}{Occupational status Marital Status}\tabcellsep Government employee Daily laborer Merchant House wife Others** Married Unmarried\tabcellsep 51 12 66 97 0 214 12\tabcellsep 22.6 5.3 29.2 42.9 0 94.7 5.3\tabcellsep Global Journal of\\
\tabcellsep \tabcellsep Cannot read and write\tabcellsep 27\tabcellsep 11.9\tabcellsep \\
\multicolumn{2}{l}{Husband Educational}\tabcellsep Can read and write\tabcellsep 48\tabcellsep 21.2\tabcellsep \\
status\tabcellsep \tabcellsep Primary education\tabcellsep 50\tabcellsep 22.2\tabcellsep \\
\tabcellsep \tabcellsep Secondary and above\tabcellsep 101\tabcellsep 44.7\tabcellsep \\
\multicolumn{2}{l}{Family size}\tabcellsep 1-3 4-6\tabcellsep 43 121\tabcellsep 19.0 53.5\tabcellsep \\
\multicolumn{2}{l}{Family income}\tabcellsep >6\tabcellsep 62\tabcellsep 27.5\tabcellsep \end{longtable} \par
 
\caption{\label{tab_1}Table 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{2} \par 
\begin{longtable}{P{0.2664179104477612\textwidth}P{0.31716417910447764\textwidth}P{0.11206467661691542\textwidth}P{0.15435323383084576\textwidth}}
Variable\tabcellsep Category\tabcellsep Frequency\tabcellsep Percent\\
Gravidity\tabcellsep Primigravida Multigravida\tabcellsep 30 196\tabcellsep 13.3 86.7\\
\tabcellsep Nulliparous\tabcellsep 0\tabcellsep 0\\
Parity\tabcellsep Primiparous\tabcellsep 30\tabcellsep 13.3\\
\tabcellsep Multiparous\tabcellsep 196\tabcellsep 86.7\\
\tabcellsep First\tabcellsep 43\tabcellsep 19.0\\
Trimester\tabcellsep Second\tabcellsep 131\tabcellsep 58.0\\
\tabcellsep Third\tabcellsep 52\tabcellsep 23.0\\
Time of registration\tabcellsep <16 weeks (Early) ?16 weeks (Late)\tabcellsep 201 25\tabcellsep 88.9 11.1\\
Number of Visits\tabcellsep ?4 >4\tabcellsep 144 82\tabcellsep 63.7 36.3\\
Distance from health facility\tabcellsep ?30 minutes >30 minutes\tabcellsep 101 125\tabcellsep 44.7 55.3\\
Get Medical advice about IFAS\tabcellsep Yes No\tabcellsep 180 46\tabcellsep 79.6 20.4\end{longtable} \par
 
\caption{\label{tab_2}Table 2 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{3} \par 
\begin{longtable}{P{0.48928046989721\textwidth}P{0.10359765051395008\textwidth}P{0.09860499265785609\textwidth}P{0.0736417033773862\textwidth}P{0.08487518355359765\textwidth}}
Variables\tabcellsep Adhered No. (\%)\tabcellsep None adhered No. (\%)\tabcellsep Chi-square\tabcellsep p-value\\
Educational status\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
Cannot read and write\tabcellsep 36\tabcellsep 40\tabcellsep \tabcellsep \\
Can read and write\tabcellsep 42\tabcellsep 18\tabcellsep \tabcellsep \\
Primary education\tabcellsep 38\tabcellsep 20\tabcellsep 8.3811\tabcellsep 0.38758\\
Secondary and above\tabcellsep 20\tabcellsep 12\tabcellsep \tabcellsep \\
total\tabcellsep 136\tabcellsep 90\tabcellsep \tabcellsep \\
Monthly family income\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
< 500\tabcellsep 36\tabcellsep 24\tabcellsep \tabcellsep \\
500 -1000\tabcellsep 28\tabcellsep 22\tabcellsep \tabcellsep \\
> 1000\tabcellsep 31\tabcellsep 20\tabcellsep 0.6008\tabcellsep 0.896258\\
1000-3000\tabcellsep 41\tabcellsep 24\tabcellsep \tabcellsep \\
Total\tabcellsep 136\tabcellsep 90\tabcellsep \tabcellsep \\
Gravidity\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
Primigravida\tabcellsep 91\tabcellsep 31\tabcellsep \tabcellsep \\
Multigravida\tabcellsep 45\tabcellsep 59\tabcellsep 22.9821\tabcellsep 0.00001\\
Total\tabcellsep 136\tabcellsep 90\tabcellsep \tabcellsep \\
Trimester\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
First\tabcellsep 40\tabcellsep 31\tabcellsep \tabcellsep \\
Second Third\tabcellsep 44 52\tabcellsep 34 25\tabcellsep 2.6369\tabcellsep 0.267558\\
Total\tabcellsep 136\tabcellsep 90\tabcellsep \tabcellsep \\
Time of regiratation\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
Early (?16 weeks)\tabcellsep 102\tabcellsep 52\tabcellsep \tabcellsep \\
Late (>16 weeks)\tabcellsep 34\tabcellsep 38\tabcellsep 7.3997\tabcellsep 0.006523\\
Total\tabcellsep 136\tabcellsep 90\tabcellsep \tabcellsep \\
History of anemia current pregnancy\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
Yes\tabcellsep 99\tabcellsep 52\tabcellsep \tabcellsep \\
No\tabcellsep 37\tabcellsep 38\tabcellsep 5.5078\tabcellsep 0.018932\\
Total\tabcellsep 136\tabcellsep 90\tabcellsep \tabcellsep \\
Knowledge of anemia\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
Poor\tabcellsep 48\tabcellsep 62\tabcellsep \tabcellsep \\
Good\tabcellsep 88\tabcellsep 28\tabcellsep 24.4671\tabcellsep 0.00001\\
Total\tabcellsep 136\tabcellsep 90\tabcellsep \tabcellsep \\
Knowledge of IFAS\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
Poor Good\tabcellsep 31 105\tabcellsep 28 62\tabcellsep 1.942\tabcellsep 0.163449\end{longtable} \par
 
\caption{\label{tab_3}Table 3 :}\end{figure}
 			\footnote{© 2019 Global Journals} 		 		\backmatter   			 
\subsection[{Acknowledgement}]{Acknowledgement}\par
We would like to express our deepest gratitude to Jimma University College of Health Sciences for financially supporting us. Our appreciation also goes to our data collectors, supervisors and study participants for their valuable contribution in the realization of this study. 			  			 
\subsection[{Availability of data and materials}]{Availability of data and materials}\par
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. But all data generated or analyzed during this study are included in this published article [and its supplementary information files]. 
\subsection[{Competing Interests}]{Competing Interests}\par
The authors declare that they have no competing interests. 
\subsection[{Funding}]{Funding}\par
This study was not funded by a grant. The study was funded by the Jimma University. There have been no reimbursements, fees, funding, nor salary from any organization that depends on or influence the results and publication of this study. 
\subsection[{Author contributions}]{Author contributions}\par
MT: conceptualized, designed the study, collect, analyzed interpretation the data, advising the whole research paper and also drafting of the manuscript. AF: conceptualized, designed the study, collect, analyzed and interpretation of the data and also drafting manuscript.			 			  				\begin{bibitemlist}{1}
\bibitem[Gebremedhin et al.]{b27}\label{b27} 	 		\textit{},  		 			Samson Gebremedhin 		,  		 			Aregash Samuel 		,  		 			Tibebu Girmamamo 		,  		 			Tsehai Moges 		,  		 			Assefa 		.  		 	 
\bibitem[Samuel et al. ()]{b29}\label{b29} 	 		\textit{},  		 			P Samuel 		,  		 			P Scott 		,  		 			Lenis 		,  		 			E Chen-Edinboro 		,  		 			Laura 		,  		 			Caulfield 		.  	 	 		\textit{The Impact of Anemia on Child Mortality: An Updated Review}  		2014. 6 p. .  	 
\bibitem[Casey et al. ()]{b4}\label{b4} 	 		‘A free weekly ironfolic acid supplementation and regular deworming program is associated with improved hemoglobin and iron status indicators i6. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States’.  		 			G Casey 		,  		 			L Phuc 		,  		 			A Macgregor 		,  		 			T Montresor 		,  		 			N Mihrshahi 		,  		 			Tien 		.  	 	 		\textit{MMWR Morb Mortal Wkly Rep}  		2009. 1998. BMC Public Health. 47 p. .  	 	 (n Vietnamese women) 
\bibitem[Addis Ababa, Ethiopia and Calverton Ethiopia Demographic and Health Survey. Central Statistical Agency and ICF International ()]{b6}\label{b6} 	 		‘Addis Ababa, Ethiopia and Calverton’.  	 	 		\textit{Ethiopia Demographic and Health Survey. Central Statistical Agency and ICF International},  				 (Maryland, USA)  		2005.  		 			CSA (Central Statistical Agency 		 	 
\bibitem[Addis Ababa, Ethiopia and Calverton Ethiopia Demographic and Health Survey. Central Statistical Agency and ICF International ()]{b7}\label{b7} 	 		‘Addis Ababa, Ethiopia and Calverton’.  	 	 		\textit{Ethiopia Demographic and Health Survey. Central Statistical Agency and ICF International},  				 (Maryland, USA)  		2011.  		 			CSA (Central Statistical Agency 		 	 
\bibitem[Abdullahi et al. ()]{b0}\label{b0} 	 		\textit{Antenatal iron and folic acid supplementation use by pregnant women in Khartoum},  		 			H Abdullahi 		,  		 			G Gasim 		,  		 			A Saeed 		,  		 			A Imam 		,  		 			I Adam 		.  		2014. Sudan. BMC Public Health. 7.  	 
\bibitem[Titaley et al. ()]{b32}\label{b32} 	 		‘Antenatal iron/folic acid supplements, but not postnatal care, prevents neonatal deaths in Indonesia: analysis of Indonesia Demographic and Health Surveys’.  		 			C R Titaley 		,  		 			M J Dibley ; Titaley 		,  		 			CR 		,  		 			M J Dibley 		.  	 	 		\textit{Asia Pac J ClinNutr}  		2012. 2002/2003-2007. 2015. 2002. 2003 and 2007. 33  (1)  p. 24.  	 	 (BMJ) 
\bibitem[Ibrahim et al. ()]{b18}\label{b18} 	 		‘Assessment of Adherence to Iron and Folic Acid Supplementation and Prevalence of Anemia in Pregnant Women’.  		 			Z Ibrahim 		,  		 			H El-Hamid 		,  		 			S Mikahil 		,  		 			Khatttab 		.  	 	 		\textit{Medical Journal of Cairo University}  		2011. 79  (2)  p. .  	 
\bibitem[Gebre et al. ()]{b1}\label{b1} 	 		‘Assessment of Factors Associated with Adherence to Iron-Folic Acid Supplementation Among Urban and Rural Pregnant Women in North Western Zone of Tigray, Ethiopia: Comparative Study’.  		 			Abel Gebre 		,  		 			Mulugeta Afework 		,  		 			Etana Belachew 		.  	 	 		\textit{International Journal of Nutrition and Food Sciences}  		2015. 4  (2)  p. .  	 
\bibitem[Best practice, progress updates, initatives and artiticles, special bulletin ()]{b13}\label{b13} 	 		\textit{Best practice, progress updates, initatives and artiticles, special bulletin},  		2012.  	 	 (FMOH (Fedreal Ministry of Health)) 
\bibitem[Abinet Arega Sadore et al. ()]{b2}\label{b2} 	 		‘Compliance with Iron-Foliate Supplement and Associated Factors among Antenatal Care Attendant Mothers in Misha District, South Ethiopia: Community Based Cross Sectional Study’.  		 			Abinet Arega Sadore 		,  		 			Mamusha Aman Lakew Abebe Gebretsadik 		,  		 			Hussen 		.  		 \xref{http://dx.doi.org/10.1155/2015/781973}{10.1155/2015/781973}.  		 \url{http://dx.doi.org/10.1155/2015/781973}  	 	 		\textit{Journal of Environmental and Public Health}  		2015.  	 
\bibitem[Mithra et al. ()]{b21}\label{b21} 	 		‘Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India’.  		 			P Mithra 		,  		 			B Unnikrishnan 		,  		 			T Rekha 		,  		 			K Nithin 		,  		 			K Mohan 		,  		 			V Kulkarni 		.  	 	 		\textit{African Health Sciences}  		2014. 14  (1)  p. .  	 
\bibitem[Coverage, compliance and factors associated with utilization of iron supplementation during pregnancy in eight rural districts of Ethiopia: a cross-sectional study]{b28}\label{b28} 	 		\textit{Coverage, compliance and factors associated with utilization of iron supplementation during pregnancy in eight rural districts of Ethiopia: a cross-sectional study},  		BMC Public Health.  	 
\bibitem[Peña-Rosas et al. ()]{b26}\label{b26} 	 		\textit{Daily oral iron supplementation during pregnancy},  		 			J P Peña-Rosas 		,  		 			L M De-Regil1 		,  		 			T Dowswell 		,  		 			F E Viteri 		.  		2014. BMC Public Health.  	 
\bibitem[Debremarkos town administration public health faclilities antenatal care clinic report ()]{b10}\label{b10} 	 		\textit{Debremarkos town administration public health faclilities antenatal care clinic report},  		2015.  	 	 (Unpulished document) 
\bibitem[Lacerte et al. ()]{b20}\label{b20} 	 		‘Determinants of Adherence to Iron/Foliate Supplementation During Pregnancy in Two Provinces in Cambodia’.  		 			P Lacerte 		,  		 			M Pradipasen 		,  		 			P Temcharoen 		,  		 			N Imamee 		,  		 			Thavatchai Vorapongsathorn 		.  	 	 		\textit{Asia-Pacific Journal of Public Health}  		2011. 23  (3)  p. .  	 
\bibitem[Nisar and Dibley ()]{b23}\label{b23} 	 		‘Earlier Initiation and Use of a Greater Number of Iron-Folic Acid Supplements during Pregnancy Prevents Early Neonatal Deaths in Nepal and Pakistan’.  		 			Y Nisar 		,  		 			M Dibley 		.  	 	 		\textit{PLoS one}  		2014.  (11)  p. 9.  	 
\bibitem[Dinga et al. ()]{b11}\label{b11} 	 		\textit{Factors associated with adherence to iron/foliate supplementation among pregnant women attending antenatal clinic at thika district hospital in kiambu county},  		 			L Dinga 		,  		 			A Mwangi 		,  		 			G Abong 		.  		2013. Kenya.  	 
\bibitem[Bekeletaye et al. ()]{b31}\label{b31} 	 		‘Factors associated with compliance of prenatal iron foliate supplementation among women in Mecha district, Western Amhara: a cross-sectional study’.  		 			Gedefaw Bekeletaye 		,  		 			Alemetsehaye Abeje 		,  		 			Mekonen 		.  	 	 		\textit{Pan African Medical Journal}  		2015.  (43)  p. 20.  	 
\bibitem[Nisar et al. ()]{b24}\label{b24} 	 		‘Factors associated with non-use of antenatal iron and folic acid supplements among Pakistani women: a cross sectional household survey’.  		 			Y Nisar 		,  		 			M Dibley 		,  		 			A Mir 		.  	 	 		\textit{BMC Pregnancy and Childbirth}  		2014.  (305)  p. 14.  	 
\bibitem[Ogundipe et al. ()]{b25}\label{b25} 	 		‘Factors associated with prenatal folic acid and iron supplementation among 21,889 pregnant women in Northern Tanzania: A cross-sectional hospital-based study’.  		 			O Ogundipe 		,  		 			C Hoyo 		,  		 			T Stbye 		,  		 			O Oneko 		,  		 			R Manongi 		,  		 			R Lie 		.  	 	 		\textit{BMC Public Health}  		2012.  (481)  p. 12.  	 
\bibitem[Wulandari et al. ()]{b37}\label{b37} 	 		‘Foetal Health Locus of Control and iron supplementation adherence among pregnant women in Bali’.  		 			L Wulandari 		,  		 			P Craig 		,  		 			A Klinken 		,  		 			Whelan 		.  	 	 		\textit{Journal of Reproductive and Infant Psychology}  		2013.  	 
\bibitem[Stoltzfus and Dreyfuss ()]{b30}\label{b30} 	 		\textit{Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia},  		 			R J Stoltzfus 		,  		 			M L Dreyfuss 		.  		1998. ILSI Press. p. .  	 
\bibitem[Haemoglobin concentrations for the diagnosis of Anemia and assessment of severity ()]{b35}\label{b35} 	 		\textit{Haemoglobin concentrations for the diagnosis of Anemia and assessment of severity},  		2012. Geneva, Switzerland, WHO; Geneva, Switzerland, WHO.  	 	 (Guideline: Daily iron and folic acid supplementation in pregnant women) 
\bibitem[Burke et al. ()]{b3}\label{b3} 	 		‘Identification, Prevention and Treatment of Iron Deficiency during the First 1000 Days’.  		 			R Burke 		,  		 			J Leon 		,  		 			P Suchdev 		.  	 	 		\textit{Nutrients}  		2014. 6 p. .  	 
\bibitem[Implementation Guidelines for the Prevention and Control of Micronutrient Deficiencies ()]{b14}\label{b14} 	 		\textit{Implementation Guidelines for the Prevention and Control of Micronutrient Deficiencies},  		2014. Ethiopia: FMOH.  	 	 (FMOH (Fedreal Ministry of Health)) 
\bibitem[Wendt et al. ()]{b33}\label{b33} 	 		‘Individual and Facility-Level Determinants of Iron and Folic Acid Receipt and Adequate Consumption among Pregnant Women in Rural Bihar’.  		 			A Wendt 		,  		 			R Stephenson 		,  		 			M Young 		,  		 			A Webb Girard 		,  		 			C Hogue 		,  		 			U Ramakrishnan 		.  	 	 		\textit{India. PloS}  		2015.  (3)  p. 10.  	 
\bibitem[Haidar and Pobocik ()]{b15}\label{b15} 	 		‘Iron deficiency anemia is not a rare problem among women of reproductive ages in Ethiopia: a community based cross sectional study’.  		 			J A Haidar 		,  		 			R S Pobocik 		.  	 	 		\textit{BMC Blood Disorders}  		2009.  	 
\bibitem[Iron deficiency anemia: guidelines for prevention, detection and management among U.S. children and women of childbearing age ()]{b17}\label{b17} 	 		\textit{Iron deficiency anemia: guidelines for prevention, detection and management among U.S. children and women of childbearing age},  		1993. Washington, DC: National Academy Press.  		 			Institute of Medicine 		 	 	 (Food and Nutrition Board) 
\bibitem[Kumar et al. ()]{b19}\label{b19} 	 		‘Iron-Folic Acid Intake among Pregnant Women in Anumanthai PHC of Villupuram’.  		 			S Kumar 		,  		 			S Kar 		,  		 			S Sarkar 		,  		 			Gks 		.  	 	 		\textit{Tamil Nadu. Indian Journal of Clinical Practice}  		2014.  (9)  p. 24.  	 
\bibitem[Harris ()]{b16}\label{b16} 	 		‘New insights into placental iron transport’.  		 			E Harris 		.  	 	 		\textit{Nutr Rev}  		1992. 50 p. .  	 
\bibitem[Fiedler et al. ()]{b12}\label{b12} 	 		\textit{Nutrition Technical Brief: A Rapid Initial Assessment of the Distribution and Consumption of Iron-Folic Acid Tablets through Antenatal Care in Ethiopia},  		 			Jack Fiedler 		,  		 			Alexis Agostino 		,  		 			Celeste Sununtnasuk 		.  		2014.  	 
\bibitem[Nisar et al. ()]{b22}\label{b22} 	 		‘Perceptions of antenatal iron-folic acid supplements in urban and rural Pakistan: a qualitative study’.  		 			Y Nisar 		,  		 			A Alam 		,  		 			B Aurangzeb 		,  		 			M Dibley 		.  	 	 		\textit{BMC Pregnancy and Childbirth}  		2014.  (344)  p. 14.  	 
\bibitem[Yekta et al. ()]{b38}\label{b38} 	 		‘Role of iron supplementation in promoting maternal and fetal outcome’.  		 			Z Yekta 		,  		 			R Pourali 		,  		 			N Mladkova 		,  		 			M Ghasemi-Rad 		,  		 			F Boromand 		,  		 			K Tappeh 		.  	 	 		\textit{Therapeutics and Clinical Risk Management}  		2011. 7 p. .  	 
\bibitem[Unpulished document. Debremarkos town administration health office annual report ()]{b9}\label{b9} 	 		\textit{Unpulished document. Debremarkos town administration health office annual report},  		2014. 2014.  	 	 (Debremarkos town administration communication office annual report. Unpulished document) 
\bibitem[WHO (World Health Organization)]{b34}\label{b34} 	 		\textit{WHO (World Health Organization)},  		 	 
\bibitem[World Health Organization: Preventing and controlling iron deficiency anemia through primary health care, a guide for health administrators and Programme manager ()]{b5}\label{b5} 	 		\textit{World Health Organization: Preventing and controlling iron deficiency anemia through primary health care, a guide for health administrators and Programme manager},  		1992. Geneva: World Health Organization.  	 
\bibitem[World Health Organization: The prevalence of anaemia in women: a tabulation of available information. 2 nd ed. Geneva: World Health Organization ()]{b36}\label{b36} 	 		\textit{World Health Organization: The prevalence of anaemia in women: a tabulation of available information. 2 nd ed. Geneva: World Health Organization},  		1992.  	 
\bibitem[Debenoist et al. ()]{b8}\label{b8} 	 		\textit{Worldwide prevalence of Anemia},  		 			B Debenoist 		,  		 			E Mclean 		,  		 			I Egli 		,  		 			M Cogswell 		.  		2008. 1993-2005. Geneva.  	 
\end{bibitemlist}
 			 		 	 
\end{document}
